Investor news
Investor Relations
Azelis is a leading global innovation service provider in the specialty chemical and food ingredients industry present in 63 countries across the globe with more than 4,200 employees. Our teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 63,000 customers, supported by 2,800 principal relationships, generating a revenue of €4.2 billion (2023).
Across our extensive network of more than 70 application laboratories, our award-winning staff help develop formulations and provide technical guidance throughout the customers’ product development process. We combine a global market reach with a local footprint to offer a reliable, integrated and unique digital service to local customers and attractive business opportunities to principals. Top-industry rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest and transparent relationships with our people and partners.
What is Azelis' value proposition?
- A global leader in specialty chemicals and food ingredients industry
- Growth driven by leadership in innovation, digitalization and sustainability
- Resilient business model with consistent organic and acquisition-driven growth
Key figures
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Revenue (€m) | 2,095.0 | 2,222.9 | 2,827.3 | 4,109.1 | 4,152 |
Gross Profit (€m) | 444.7 | 486.1 | 650.1 | 960.7 | 984.1 |
Gross Profit Margin (%) | 21.2% | 21.9% | 23.0% | 23.4% | 23.7% |
Adjusted EBITA¹ (€m) | 163.3 | 189.6 | 267.9 | 456.9 | 466.3 |
Adjusted EBITA Margin (%) | 7.8% | 8.5% | 9.5% | 11.1% | 11.2% |
Free Cash Flow² (€m) | 137.2 | 188.3 | 181.6 | 438.0 | 601.2 |
Free Cash Flow conversion³ (%) | 82.8% | 98.4% | 67.1% | 94.8% | 127.4% |
¹ Adjusted EBITA = Operating profit or loss before amortization and impairment of intangible assets and excluding adjustments
² Free Cash Flow = Adjusted EBITDA less lease payments, plus changes in Net Working Capital, plus changes in other assets liabilities and provisions, less net capital expenditures
³ Free Cash Flow Conversion = Free Cash Flow divided by Adjusted EBITDA less lease payments
Financial news
Azelis strengthens its food and nutraceuticals footprint in Poland with the acquisition of Hortimex
Azelis prices Offering of €600 Million 4.750% Senior Notes due 2029
Azelis corporate animation video
Please reach out to us via
investor-relations@azelis.com.